You have 9 free searches left this month | to do more

linagliptin

Linagliptin is a drug used to treat Diabetes Mellitus, Type 2, Healthy, Diabetes, and other conditions. Linagliptin is being actively studied in 4 studies and prior, has been studied in 60.

Top SponsorsTop SitesTop Investigators
Boehringer IngelheimAmerican Health NetworkGuillermo Umpierrez, MD
Emory UniversityAsan Medical CenterAnil Bhansali
Hoffmann-La RocheDaishinkai Medical Corporation Ookuma HospitalAristidis Veves
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Completed
  • Schizophrenia
  • Linagliptin
  • Reno, Nevada
    University of Nevada School of Medicine
2020-11-05
Nov 5, 2020
B
Completed
  • Diabetes Mellitus, Type 2
  • Beijing, China
  • +4 more
2021-09-02
Sep 2, 2021
M
Completed
  • Type 2 Diabetes
  • Coronary Artery Disease
  • Linagliptin
  • Placebo
  • Graz, Austria
    Medical University of Graz, Department for Internal Medicine
2020-05-14
May 14, 2020
U
Withdrawn
  • Coronavirus Infection
  • Type 2 Diabetes
  • Linagliptin
  • Insulin regimen
  • Miami, Florida
    University of Miami
2021-06-07
Jun 7, 2021
H
Completed
  • Diabetes Mellitus, Type 2
  • Left Ventricular Systolic Dysfunction
  • Linagliptin
  • Placebo
  • Bergamo, BG, Italy
  • +18 more
2021-05-21
May 21, 2021
G
Completed
  • Type 2 Diabetes
  • Impaired Renal Function
  • Linagliptin
  • Placebo
  • Washington, District of Columbia
    The George Washington University Medical Faculty Associates
2020-02-03
Feb 3, 2020
U
Completed
  • Type 2 Diabetes
  • Hellerup, Denmark
    Center for Diabetes Research, Gentofte Hospital, Copenhagen Univ
2020-04-06
Apr 6, 2020
B
Completed
  • Healthy
  • Empagliflozin, Metformin HCl, Linagliptin (fixed dose combination)
  • +3 more
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
2020-02-06
Feb 6, 2020
S
Completed
  • Type2 Diabetes Mellitus
  • +2 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
2019-09-19
Sep 19, 2019
B
Completed
  • Diabetes Mellitus, Type 2
  • Linagliptin
  • Eden Prairie, Minnesota
    Optum
2019-02-01
Feb 1, 2019
E
Completed
  • Type 2 Diabetes
  • Linagliptin
  • +3 more
  • Denver, Colorado
  • +4 more
2019-02-18
Feb 18, 2019
H
Completed
  • Type2 Diabetes Mellitus
  • Seoul, Korea, Republic of
    Asan Medical Center
2019-02-20
Feb 20, 2019
B
Active, not recruiting
  • Diabetes
  • Boston, Massachusetts
    Brigham & Women's Hospital
2020-01-28
Jan 28, 2020
B
Completed
  • Diabetes Mellitus, Type 2
  • Linagliptin
  • +5 more
  • Aichi, Nagoya, Japan
  • +39 more
2018-09-24
Sep 24, 2018
B
Completed
  • Diabetes Mellitus, Type 2
  • placebo
  • +2 more
  • Beijing, China
  • +24 more
2020-03-24
Mar 24, 2020
M
Terminated
  • Schizophrenia
  • Linagliptin
  • Bandar Tun Razak, Kuala Lumpur, Malaysia
    Pusat Perubatan Universiti Kebangsaan Malaysia
2018-08-14
Aug 14, 2018
R
Unknown status
  • New Onset Diabetes After Transplant
  • Kidney Transplant; Complications
  • Shanghai, Shanghai, China
    Department of nephrology, endocrinology and kidney transplantati
2018-08-20
Aug 20, 2018
E
Completed
  • Diabetes
  • linagliptin
  • insulin glargine
  • Atlanta, Georgia
  • +3 more
2018-07-25
Jul 25, 2018
B
Recruiting
  • Diabetes Mellitus, Type 2
  • Linagliptin
  • +2 more
  • Phoenix, Arizona
  • +91 more
2021-10-05
Oct 5, 2021
U
Completed
  • Chronic Kidney Diseases
  • Type 2 Diabetes
  • Seattle, Washington
    University of Washington
2018-09-12
Sep 12, 2018
U
Completed
  • Type 2-diabetes
  • Linagliptin
  • Placebo
  • Erlangen, Germany
  • +1 more
2018-01-11
Jan 11, 2018
S
Withdrawn
  • Diabetic Nephropathy Type 2
  • Linagliptin
  • +3 more
  • Gentofte, Denmark
    Steno Diabetes Center Copenhagen
2018-09-12
Sep 12, 2018
U
Unknown status
  • Type 2 Diabetes
  • Linagliptin
  • Placebo
  • Buffalo, New York
    ECMC Ambulatory Center, 3rd Floor
2017-11-02
Nov 2, 2017